Key: [Impact Factor] + [Citations]
Publications available in PDF form are linked below.
Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. The Lancet 2008; 371: 915–22.
White HD, Dalby AJ. Heart disease in Soweto: facing a triple threat. The Lancet; 371:876-7.
Damasceno A, Cotter G, Dzudie A, Sliwa K, Mayosi B. Heart failure in Africa-Time for action. J Am Coll Cardiol; 2007.
Inglis S, Stewart S, Papachan A, Vaghela V, Libhaber C, Veriava Y, Sliwa K. Anaemia and Renal Function in Heart Failure due to Idiopathic Dilated Cardiomyopathy. Europ J Heart Failure; 2007.
Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H. A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy. Cell; February, 2007. Also see editorial.
Inglis S, Stewart S, Papachan A, Vaghela V, Libhaber, C, Veriava Y, Sliwa K. Anaemia and renal function in heart failure due to idiopathic dilated cardiomyopathy.
Amira C, Ntyintyane L, Wilkinson D, Stewart S, Becker A, Libhaber E, Sliwa K. Emerging epidemic of cardiovascular disease among urban Africans: Acute coronary syndrome at Baragwanath Hospital, Soweto. SA Heart; Spring 2006.
Forster O, Essop M, Sliwa K. Present concepts of the aetiology, diagnosis and treatment of peripartum cardiomyopathy. SA Heart; Spring 2006.
Sliwa K, Fett J, Elkayam U. Peripartum Cardiomyopathy – a common condition in many parts of the world. The Lancet; 17 August 2006. [21.3]
Forster O, Ansari T, Becker A, Yip A, Tshane W, Sliwa K. Therapeutic management of Peripartum Cardiomyopathy. Women Health 2006.
Stewart S, Wilkinson D, Becker A, Askew D, Ntyintyane, McMurray J, Sliwa K. Mapping the emergence of heart disease in a black, urban population in Africa: The Heart of Soweto Study. Intern J Cardiol 2006; 101:101-108. [2.1]
Mayosi B, Wiysonge C, Ntsekhe M, Volmik J, Gumedze F, Maartens G, Aje A, Thomas B, Thomas K, Awotedu A, Thembela B, Mntla P, Maritz F, Ngu Blackett, Sliwa K, Vezi B, Alam N, Brown B, Gould T, Visser T, Shey M, Commerford P. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV area: The investigation of Management of pericarditis in Africa (IMPI Africa) registry. BMC Infectious Diseases 2006: 6:2 doi 10.1186/1471-2334-6-2. [2.1]
Sliwa K, Forster O, Libhaber E, Fett J, Sundstrom JB, Hilfiker-Kleiner D, Ansari. Peripartum Cardiomyopathy: Inflammatory markers as predictors of outcome in 100 prospective studied patients. Eur Heart J 2006; 27(4):441-6. [6.2]
Sliwa K, Damasceno A, Mayosi B. Cardiomyopathy in Africa. Circulation 2005; 112:3577-3583. [12.6]
Brooksbank R, Woodiwiss A, Sliwa K, Badenhorst D, Deftereos D, Wadee A, Essop MR, Sareli P, Norton G. Endotoxin-independent white cell cytokine production in heamodynamically stable patients with idiopathic dilated cardiomyopathy. Cardiovasc J South Afr 2005;16:260-265. [1.2]
Brooksbank R, Woodiwiss A, Sliwa K, Deftereos D, Essop MR, Sareli P, Norton G. Sustained white cell cytokine activation in idiopathic dilated cardiomyopathy despite haemodynamic improvement with medical therapy. Cardiovasc J South Afr; 2005;16:200-204. [1.2]
ICRAM: (The international Campaign to Revitalize Academic Medicine): The path to academic medicine: living your life-Karen Sliwa. BMJCAREERS 2005; 9 July 2005/ [7.0]
Steyn Krisela, Sliwa K, Hawken S, Ounpuu S, Yusuf S. Africa Interheart Study. Circulation 2005; 112:3554-3561. [12.6] + [6]
Wairraich R, Sliwa K, Damasceno A, Carraway R, Sundstrom B, Arif G, Essop R, Ansari A, Fett J, Yacoub M. Impact of pregnancy related heart failure on humoral immunity immunity: Clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopcathy. Am Heart J 2005;150:263-9.
Sliwa K, Essop MR. Reply. J Am Coll Cardiol.2005;5:183. [9.1]
Aswasthi S, Clark J, Hadridge P, Marusic A, Purcell G, Sliwa K, Smith R, Tan Torres T, Tugwell P, Ward R on behalf of the International campaign to Revitalise Academic Medicine. PLoS Medicine/www.plosmedicine.org July 2005, Vol 2, Issure 7, e207. [3.2]
Libhaber EN, Norton GR, Libhaber CD, Candy GP, Woodiwiss AJ, Sliwa K, Essop MR, Sareli P. Change in blood pressure predicts regression of cardiac hypertrophy in patients of African ancestry receiving agents influencing the rennin-angiotensin system. Journal of Hum Hypertension 2005;doi:10.1038/sj.jhh.1001879. [3.2]
Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed W, Ngu Blackett K, Chitr-Sitthi A, Sato H, Yusuf S, for the INTERHEART investigators. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13648 controls form 52 countries (The INTERHEART study); case-control study. The Lancet 2004;364:912-4. [21.7] + [42]
Sliwa K, Norton G, Kone N, Candy G, Kachope J, Woodiwiss J, Libhaber C,Sareli P, Essop R. Impact of initiating carvedilol Before Angiotensin Converting Enzyme inhibitor Therapy on Cardiac Function in newly Diagnosed Heart Failure. J Am Coll Cardiol 2004;44:1825-30. [9.1] + [13]
Libhaber E, Libhaber C, Candy G, Sliwa K, Kachope J, Hlatshwayo N, Puane M, Woodiwiss A, Norton G, Essop M, Sareli P. Effects of slow-release Indapamide and perindopril as compared to amlodipine in 24-hour blood pressure and left ventricular mass in patients of African ancestry. Am J Hypertens. 2004 17:428-32. [2.2]
Sliwa K, Forster O, Zhanje F, Candy G, Kachope J, Essop R. Subsequent pregnancy in patients with peripartum cardiomyopathy. Am J Cardiol 2004;93:1441-1443. [3.2] + [13]
Munclinger M, Thornton AS, Schutte D, Sliwa K. Fatal potential of supraventricular tachycardia in hypertrophic cardiomyopathy. Int J Cardiol 2004 Feb; 93:335-337. [2.1]
Sliwa K, Woodiwiss A, Kone V, Badenhorst D, Norton G, Zambakides C, Peters F, Essop MR. Therapy of ischaemic left ventricular dysfunction with the immuno-modulating agent pentoxifylline: results of a randomised study. Circulation 2004;109:750-755. [12.6] [10]
Sliwa K, Woodiwiss A, Libhaber E, Zhanje F, Motara R, Libhaber C, Essop MR. C-reactive protein predicts improved systolic performance in patients with idiopathic dilated cardiomyopathy treated with Pentoxifylline. Eur J Heart Fail. 2004:6:731-4. [2.8] + [4]
Papachan A, Sliwa K, Essop MR. Cardiac Amyloidosis presenting as Pseudo Hypertrophic Cardiomyopathy. Cardiovasc J South Afr 2004;15;136-138.
62. Vaghela VP, Sliwa K, Essop MR, Sanderson JE. Beta-adrenergic receptor blockers as part of management of heart failure therapy in Africa-very little evidence. Europ. J. Heart Fail. 2006, Vol. 5, Supplement 1, June (abstract 760)
61. Forster O, Hilfiker-Kleiner, Yip A, Becker A, Nel M, Sliwa K. Bromocryptine prevents deterioration with PPCM after subsequent pregnancy. Europ. J. Heart Fail. 2006, Vol. 5, Supplement 1, June (abstract 551)
60. Forster O, Sundstrom JB, Tshani W, Nel MJ, Becker A, Yip A, Ansari AA, Essop MR, Sliwa K. Pro-inflammatory cytokines (IL-1a, IL-6, tumour necrosis factor-alpha) might be lacking inhibition via nitric oxide due to high levels of transforming growth factor-beta1 in peripartum cardiomyopathy. South African Medical Journal 2005. Vol. 95, No. 10: 805
59. Forster O, Sundstrom JB, Tshani W, Nel MJ, Becker A, Yip A, Ansari AA, Essop MR, Sliwa K. Absence of a role of human T-lymphotropic viruses (HTLV-I/II) in the pathogenesis of peripartum cardiomyopathy. South African Medical Journal 2005. Vol. 95, No. 10: 805
58. Forster O, Wallukat G, Ansari AA, Sundstrom JB, Becker A, Yip A, Essop MR, Sliwa K. Elevated levels of plasma immunoglobulin G in both HIV-1 infected and non-infected patients with peripartum cardiomyopathy on standard heart failure therapy. South African Medical Journal 2005. Vol. 95, No. 10: 806
57. Forster O, Sundstrom JB, Ansari AA, Tshani W, Nel MJ, Becker A, Yip A, Essop MR, Sliwa K. Heart failure therapy leads to significant reduction of absolute CD4 counts in HIV-1 negative but not in HIV-1 positive patients with peripartum cardiomyopathy. South African Medical Journal 2005. Vol. 95, No. 10: 806
56. Forster O, Sundstrom JB, Ansari AA, Tshani W, Nel MJ, Becker A, Yip A, Essop MR, Sliwa K. HIV-1 infection does not influence the kinetics of cardiac function improvement in patients with peripartum cardiomyopathy treated with standard heart failure therapy. South African Medical Journal 2005. Vol. 95, No. 10: 807
55. Forster O, Sundstrom JB, Ansari AA, Tshani W, Nel MJ, Becker A, Yip A, Essop MR, Sliwa K. Increased levels of big-endothelin-1 are characteristic in peripartum cardiomyopathy but do not predict clinical outcome. South African Medical Journal 2005. Vol. 95, No. 10: 807
54. O Forster, J Sundstrom, K Sliwa, W Tshani, MJ Nel, A Becker, MR Essop, A Ansari. Elevated levels of transforming growth factor –beta 1 (TGF-beta 1) as a potential cause for platelet aggregation and tissue damage in peripartum cardiomyopathy. European Journal of Heart Failure 2005. Supplement 1 Vol. 4: 1
53. O Forster, JB Sundstrom, K Sliwa, MJ Nel, W Tshani, A Becker, MR Essop, AA Ansari. Big endothelin-1 levels are associated with New York Heart Association
functional class in peripartum cardiomyopathy. European Journal of Heart
Failure 2005. Supplement 1 Vol. 4: 30
52. O Forster, JB Sundstrom, AA Ansari, W Tshani, MJ Nel, A Becker, MR Essop, K Sliwa. Significant improvement of left ventricular function in peripartum cardiomyopathy independent from HIV status. European Journal of Heart Failure 2005. Supplement 1 Vol. 4: 146
51. O Forster, G Wallukat, AA Ansari, JB Sundstrom, A Becker, A Yip, MR Essop, K Sliwa. Sustained hypergammaglobulinaemia in HIV negative and HIV positive patients with peripartum cardiomyopathy following heart failure therapy. European Journal of Heart Failure 2005. Supplement 1 Vol. 4: 192
50. Forster O, Libhaber E, Libhaber C, Abassi H, Becker A, Yip A, Essop MR, Sliwa K. Peripartum Cardimyopathy: Inflammatory markers as predictors of clinical outcome in 100 patients. Journal of Molecular and Cellular Cardiology 2004; 37: 237
49. Forster O, Libhaber E, Kachope J, Abassi H, Pappachan A, Essop MR, Sliwa K.
Peripartum Cardiomyopathy: Correlation between cholesterol, C-reactive protein and left ventricular dysfunction. Journal of Molecular and Cellular Cardiology 2004; 37: 292
48. Forster O, Libhaber E, Libhaber C, Abassi H, Becker A, Yip A, Essop MR, Sliwa K. Predictors of mortality in 100 prospectively studied patients with peripartum cardiomyopathy. Journal of Molecular and Cellular Cardiology 2004; 37: 237
47. Warraich R. Fett J, Frenneaux M, Sliwa K. Yacoub M. Association of G3-subclass immunoglobulins and NYHA functional status in patients with peripartum cardiomyopathy: Relative impact of pregnancy related heart failure on humoral immunity.
Journal of Heart and Lung Transplantation, Supplement, Feb 2005;24:S119.
46. Sliwa K, Libhaber E, Forster O, Libhaber C, Abbasi H, Essop R. Peripartum Cardiomyopathy: Inflammatory markers as predictors of outcome in 100 prospective studied patients. Circulation. Supplement III Vol. 110, No 17, 3476.
45. Sliwa K, Woodiwiss A, Norton G, Kone N, Kachope J, Yip A, Becker A, Essop R. Initiation of Carvedilol before ACE-inhibitor therapy for the treatment of heart failure: Impact on plasma NT-proBNP. Circulation. Supplement III Vol. 110, No 17, 2262.
44. Warraich R, Fett JD, Damasceno A, Essop R, Sliwa K, Yacoub MH, (2004). Autoantibody Profiles in Peripartum Cardiomyopathy: A Clinically Distinct Entity from Idiopathic dilated Cardiomyopathy. European Journal of Cardiology (suppl) 1136.
43. Wallukat G, Bartel B, Schulze W, Forster O, Essop R, Sliwa K (2004). Autoantibodies against beta-1 adrenergic receptor in the sera of patients with peripartum cardiomyopathy: functional characterization. European Journal of Cardiology (suppl) 676
42. Sliwa K, Woodiwiss A, Forster O, Norton G, Candy G, Schutte D, Libhaber C, Essop MR (2003). Beta-blockers versus ACE-inhibitors in the initial treatment of idiopathic dilated cardiomyopathy. Cardiovascular Journal of South Africa, Vol 14, No 5
41. Machika PW, Sliwa K, Libhaber E, Maja R, Essop MR, Schutte D (2003). Indication for cardiac resynchronisation in a South African Heart Failure Clinic. Cardiovascular Journal of South Africa, Vol 14, No 5
40. Singh K, Candy GP, Libhaber C, Libhaber E, Tshele, Sareli P, Sliwa K, Essop MR (2003). Agreement between ECG and echocardiographic criteria for detecting left ventricular hypertrophy in black South Africans with hypertension. Cardiovascular Journal of South Africa, Vol 14, No 5
39. Sliwa K, Forster O, Zhanje F, Candy G, Libhaber E, Phooko B, Libhaber C, Essop MR (2003). Peripartum cardiomyopathy: clinical profile of 100 patients in a single-centre prospective study. Cardiovascular Journal of South Africa, Vol 14, No 5
38. Sliwa K, Woodiwiss A, Forster O, Kone V, Badenhorst D, Norton G, Zambakides C, Peters F, Essop Mr (2003). Therapy of ischaemic left ventricular dysfunction with the immuno-modulating agent pentoxifylline: results of a randomised study. Cardiovascular Journal of South Africa, Vol 14, No 5
37. Sliwa K, Forster O, Zhanje F, Woodiwiss A, Libhaber C, Kachope J, Essop MR (2003). Treatment of peripartum cardiomyopathy with high dose pentoxifylline as an immuno-modulatory agent in a prospective randomised trial. Cardiovascular Journal of South Africa, Vol 14, No 5
36. Sliwa K, Woodiwiss A, Norton G, Candy G, Kachope J, Schutte D, Libhaber C, Essop MR (2003). Should beta-blockers be initiated before ACE-inhibitors in the treatment of heart failure? European Journal of Cardiology ( suppl) 2820
35. Warraich R, Sliwa K, Ansari AA, Yacoub MH, Fett J (2003). Autoantibody Profiles in Peripartum Cardiomyopathy: A Clinically Distinct Entity from Idiopathic dilated Cardiomyopathy. European Journal of Cardiology (suppl)1068
34. Sliwa K, Woodiwiss A, Kone V, Badenhorst D, Norton G, Peters F, Zambakides C, Essop MR (2003). Therapy of ischaemic cardiomyopathy with the immuno-modulating agent pentoxifylline: results of a randomized trial. European Journal of Cardiology (suppl)2595
33. Sliwa K, Zhanje F, Woodiwiss A, Candy G, Libhaber C, Kachope J, Ho K, Essop MR ( 2003). High dose of the immuno-modulatory drug pentoxifylline in patients with peripartum cardiomyopathy-a prospective randomized trial. European Journal of Cardiology (suppl) 3636
32. Sliwa K, Zhanje F, Candy G, Libhaber E, Phooko B, Libhaber C, Motara R, Essop MR (2003). Peripartum Cardiomyopathy: clinical profile in 100 prospective patients studied at a single centre. European Journal of Cardiology (suppl) 3251
31. Sliwa K, Zhanje F, Kachope J, Essop R (2002) Subsequent pregnancy in patients with peripartum cardiomyopathy. European Journal of Cardiology (suppl)80138.
30. Sliwa K, Woodiwiss A, Norton G, Candy G, Badenhorst D, Libhaber C, Essop R, Sareli P (2002) Perindopril versus carvedilol in idiopathic dilated cardiomyopathy. European Journal of Cardiology (suppl)81718.
29. Sliwa K, Woodiwiss A, Norton G, Candy G, Badenhorst D, Libhaber C, Skudicky D, Sareli P (2002) Pentoxifylline improves systolic function in severe heart failure. European Journal of Cardiology (suppl)80149.
28. Sliwa K, Woodiwiss A, Zhanje F, Motara R, Libhaber C, Skudicky D, Sareli P (2002). C-reactive protein predicts improved systolic performance in patients with idiopathic dilated cardiomyopathy treated with Pentoxifylline. Journal of the American College of Cardiology 39,9 (suppl B)3095.
27. Sliwa K, Woodiwiss A, Norton G, Candy G, Badenhorst D, Libhaber C, Skudicky D, Sareli P (2002). Effects of Pentoxifylline in severe heart failure. Journal of the American College of Cardiology 39,9 (suppl B)4643
26. Sliwa K, Zhanje F, Essop MR (2001). Effect of subsequent pregnancy in patients with documented peripartum cardiomyopathy- a prospective echocardiographic and cytokine evaluation. Circulation.(suppl)3113
25. Tiago A, Woodiwiss A, Candy G, Brooksbank R, Skudicky D, Sliwa K, Sareli P, Norton G (2001). Renin-angiotensin-aldosterone sytem gene polymorthism as predictors of improvement in systolic performance in dilated cardiomyopathy. Journal of the European Society of Cardiology (suppl) 255
24. Brooksbank R, Woodiwiss AJ, Defterios D, Sliwa K, Kibirigi A, Candy G, Skudicky D, Sareli P, Norton G (2001). Association between a calcinurin B gene variant and idiopathic dilated cardiomyopathy in black South Africans. Journal of the European Society of Cardiology (suppl) 3496
23. Tiago A, Skudicky D, Woodiwiss AJ, Candy G, Brooksbank R, Sliwa K, Sareli P, Norton GR (2000). Renin-angiotensin-aldosterone system gene polymorphism as predictors of improvement in systolic performance in dilated cardiomyopathy. Cardiovascular Journal of Southern Africa. M10.3
22. Woodiwiss AJ, Brooksbank R, Sliwa K, Skudicky D, Candy G, Defterios D, Sareli P, Norton GR (2000). Tumor necrosis factor-alpha gene variant and the severity of systolic dysfunction in idiopathic dilated cardiomyopathy in black South Africans. Journal of the American College of Cardiology
21. Brooksbank RL, Woodiwiss AJ, Sliwa K, Skudicky D, Candy GP, Defterios D, Sareli P, Norton G (2000). Association between calcineurin B gene variant and idiopathic dilated Cardiomyopathy Cardiovascular Journal of Southern Africa
20. Brooksbank RL, Woodiwiss AJ, Sliwa K, Skudicky D, Candy GP, Defterios D, Sareli P, Norton G (2000). Sensitivity of white cells to lipopolysaccharide-induced tumor necrosis factor alpha production in patients with idiopathic dilated heart failure.
Cardiovascular Journal of Southern Africa
19. Skudicky D, Sliwa K, Libhaber C, Bergemann A, Candy G, Sareli P (2000). Pentoxifylline in idiopathic dilated cardiomyopathy. Cardiovascular Journal of Southern Africa
18. Sliwa K, Skudicky D, Bergemann A, Kibirigi A, Candy G, Sareli P (2000). Treatment with pentoxifylline improves outcome of patients with peripartum cardiomyopathy. Cardiovascular Journal of Southern Africa
17. Brooksbank R, Woodiwiss AJ, Skudicky D, Sliwa K, Candy G, Defterios D, Sareli P, Norton GR. Association between Calcinurin B Gene variant and idiopathic dilated cardiomyopathy in black South Africans. Cardiovascular Journal of Southern Africa
16. Sussman M, Sliwa K, Patel A (2000). AB180 circulatory support system-outcome in three patients with dilated cardiomyopathy and severe mitral regurgitation. Journal of Cardiovascular Surgery
15. Sussman M, Sliwa K, Candy G (2000). AB180 Circulatory support system-Analysis of left ventricular systolic and diastolic function, plasma levels of cytokines and FAS/Apo1. Journal of Cardiovascular Surgery
14. Sliwa K, Skudicky D, Bergemann A, Candy G, Hopley P, Sareli P (2000). Pentoxifylline improves outcome in patients with peripartum Cardiomyopathy. Journal of the European Society of Cardiology ( suppl) 1373
13. Sliwa K, Skudicky D, Bergemann A, Candy G, Sareli P (2000). Peripartum Cardiomyopathy: Analysis of Clinical Outcome, Left ventricular Function, Plasma Levels of Cytokines and Fas/APO-1. Journal American College of Cardiology (suppl) 2:165A:
12. Skudicky D, Bergemann A, Sliwa K, Candy G, Sareli P (2000). Heart Failure Research Unit. Pentoxifylline Improves Left Ventricular Performance in Patients with Idiopathic Dilated Cardiomyopathy Treated with Digoxin, Angiotensin Converting Enzyme Inhibitors and Carvedilol. Journal of the American College of Cardiology ( suppl)164A
11. Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P (2000). Baseline Plasma Levels of Tumor Necrosis Factor-alpha Predicts response to Treatment With Pentoxifylline in Patients with Idiopathic Dilated Cardiomyopathy. Journal of the American College of Cardiology (suppl) 352 A
10. Skudicky D, Sliwa K, Candy G, Bergemann A, Sareli P. Pentoxifylline reduces Fas/APO-1 plasma levels in patients with idiopathic dilated cardiomyopathy (1999). Circulation (suppl) :I-17
9. Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P (1999).
Long term effects of Pentoxifylline on left ventricular function in patients with idiopathic dilated cardiomyopathy. Journal of the European Society of Cardiology (suppl) P620
8. Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P (1998).
Pentoxifylline reduces Interleukin-6 plasma levels in patients with idiopathic dilated cardiomyopathy. Circulation (supplI):I-4
7. Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P (1998).
Effects of Pentoxifylline on left ventricular function in patients with idiopathic dilated cardiomyopathy. One year results. Circulation (Suppl I);I-650
6. Candy G, Skudicky D, Woodiwiss AJ, Luker F, Mueller U, Sliwa K, Sareli P, Norton GR (1998). The angiotensin-converting enzyme gene insertion/deletion ( I/D) polymorphism is independently associated with both a reduced left ventricular systolic performance and an increased cavity size in idiopathic dilated cardiomyopathy. South African Journal of Science
5. Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P (1998). Long-term effects of Pentoxifylline on Left ventricular function in patients with idiopathic dilated cardiomyopathy. Cardiovascular Journal of Southern Africa
4. Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P (1998). Effects of Pentoxifylline on Interleukin-6 plasma in patients with idiopathic dilated cardiomyopathy. Cardiovascular Journal of Southern Africa
3. Sliwa K, Skudicky D, Bergemann A, Candy G, Sareli P (1998). Long-term results of patients with post partum cardiomyopathy on “optimal medical therapy”. Cardiovascular Journal of Southern Africa
2. G. Candy, D. Skudicky, A.J. Woodiwiss, F. Luker, U. Muller, K. Sliwa, P. Sareli (1998). The angiotensin-converting enzyme gene insertion/deletion polymorphism, an independent predictor of systolic cardiac performance in idiopathic dilated Cardiomyopathy. Journal of the European Society of Cardiology. ( suppl): 38591
1. Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P (1998). Effects of pentoxifylline on left ventricular performance in patients with idiopathic dilated cardiomyopathy. Journal of the American College of cardiology.31.2 (suppl A): 68A